Kevin D. Bunker, Chief Operating Officer at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 20,000 shares at $77.45 ($1.6M) on 2021-12-20, disclosed to the SEC on 2021-12-21.
Open-market sale of $1.6M ZNTL by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $77.45 | 2,161 | $167K | 10.6% |
| 2 | $77.45 | 2,161 | $167K | 10.6% |
| 3 | $78.52 | 1,879 | $148K | 9.3% |
| 4 | $78.52 | 1,879 | $148K | 9.3% |
| 5 | $79.78 | 3,889 | $310K | 19.6% |
| 6 | $79.78 | 3,889 |
| $310K |
| 19.6% |
| 7 | $80.76 | 2,071 | $167K | 10.6% |
| 8 | $80.76 | 2,071 | $167K | 10.6% |
| Total | $79.24 avg | 20,000 | $1.6M | 100% |
| Filing → |
| ZNTL | SELL | 2023-02-14 | $285K | — | Filing → |
| ZNTL | SELL | 2022-08-12 | $150K | — | Filing → |
| ZNTL | SELL | 2022-07-20 | $150K | — | Filing → |